SIA, DANIELA
SIA, DANIELA
Universita' degli Studi di MILANO
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
2019 R. Pinyol, R. Montal, L. Bassaganyas, D. Sia, T. Takayama, G.Y. Chau, V. Mazzaferro, S. Roayaie, H.C. Lee, N. Kokudo, Z. Zhang, S. Torrecilla, A. Moeini, L. Rodriguez-Carunchio, E. Gane, C. Verslype, A.E. Croitoru, U. Cillo, M. de la Mata, L. Lupo, S. Strasser, J.W. Park, J. Camps, M. Solé, S.N. Thung, A. Villanueva, C. Pena, G. Meinhardt, J. Bruix, J.M. Llovet
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
2017 D. Sia, Y. Jiao, I. Martinez Quetglas, O. Kuchuk, C. Villacorta Martin, M. Castro de Moura, J. Putra, G. Camprecios, L. Bassaganyas, N. Akers, B. Losic, S. Waxman, S.N. Thung, V. Mazzaferro, M. Esteller, S.L. Friedman, M. Schwartz, A. Villanueva, J.M. Llovet
Gene-expression signature of vascular invasion in hepatocellular carcinoma
2011 B. Mínguez, Y. Hoshida, A. Villanueva, S. Toffanin, L. Cabellos, S. Thung, J. Mandeli, D. Sia, C. April, J. Fan, A. Lachenmayer, R. Savic, S. Roayaie, V. Mazzaferro, J. Bruix, M. Schwartz, S.L. Friedman, J.M. Llovet
Human CD34+ cells engineered to express membrane-bound tumor necrosis factor–related apoptosis-inducing ligand target both tumor cells and tumor vasculature
2010 C. Lavazza, C. Carlo Stella, A. Giacomini, L. Cleris, M. Righi, D. Sia, M. Di Nicola, M. Magni, P. Longoni, M. Milanesi, M. Francolini, A. Gloghini, A. Carbone, F. Formelli, A.M. Gianni
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments
2009 M. Righi, A. Giacomini, C. Lavazza, D. Sia, C. Carlo-Stella, A. Gianni
Interferon γ enhances the anti-myeloma activity of the fully human anti-HLA-DR monoclonal antibody 1D09C3
2007 C. Carlo-Stella, A. Guidetti, M. Di Nicola, C. Lavazza, L. Cleris, D. Sia, P. Longoni, M. Milanesi, M. Magni, Z. Nagy, P. Corradini, A. Carbone, F. Formelli, A.M. Gianni